FR2798392B1 - Marqueurs genetiques de la toxicite, preparation et utilisations - Google Patents

Marqueurs genetiques de la toxicite, preparation et utilisations

Info

Publication number
FR2798392B1
FR2798392B1 FR9911405A FR9911405A FR2798392B1 FR 2798392 B1 FR2798392 B1 FR 2798392B1 FR 9911405 A FR9911405 A FR 9911405A FR 9911405 A FR9911405 A FR 9911405A FR 2798392 B1 FR2798392 B1 FR 2798392B1
Authority
FR
France
Prior art keywords
toxicity
methods
genetic markers
compounds
nucleic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9911405A
Other languages
English (en)
French (fr)
Other versions
FR2798392A1 (fr
Inventor
Bruno Tocque
Laurent Bracco
Fabien Schweighoffer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ExonHit Therapeutics SA
Original Assignee
ExonHit Therapeutics SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ExonHit Therapeutics SA filed Critical ExonHit Therapeutics SA
Priority to FR9911405A priority Critical patent/FR2798392B1/fr
Priority to US09/456,370 priority patent/US6509153B1/en
Priority to JP2001523800A priority patent/JP2003509066A/ja
Priority to ES00962602T priority patent/ES2216958T3/es
Priority to PCT/FR2000/002503 priority patent/WO2001020029A2/fr
Priority to IL14861500A priority patent/IL148615A0/xx
Priority to AT00962602T priority patent/ATE263255T1/de
Priority to EP00962602A priority patent/EP1220950B9/fr
Priority to CA002380383A priority patent/CA2380383A1/fr
Priority to AU74269/00A priority patent/AU783310B2/en
Priority to DE60009530T priority patent/DE60009530T2/de
Priority to PT00962602T priority patent/PT1220950E/pt
Priority to DK00962602T priority patent/DK1220950T3/da
Publication of FR2798392A1 publication Critical patent/FR2798392A1/fr
Priority to US10/070,676 priority patent/US20030059788A1/en
Application granted granted Critical
Publication of FR2798392B1 publication Critical patent/FR2798392B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6809—Methods for determination or identification of nucleic acids involving differential detection
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
FR9911405A 1999-09-13 1999-09-13 Marqueurs genetiques de la toxicite, preparation et utilisations Expired - Fee Related FR2798392B1 (fr)

Priority Applications (14)

Application Number Priority Date Filing Date Title
FR9911405A FR2798392B1 (fr) 1999-09-13 1999-09-13 Marqueurs genetiques de la toxicite, preparation et utilisations
US09/456,370 US6509153B1 (en) 1999-09-13 1999-12-08 Genetic markers of toxicity preparation and uses
PT00962602T PT1220950E (pt) 1999-09-13 2000-09-12 Marcadores geneticos da toxicidade preparacao e utilizacao
PCT/FR2000/002503 WO2001020029A2 (fr) 1999-09-13 2000-09-12 Marquers genetiques de la toxicite, preparation et utilisations
IL14861500A IL148615A0 (en) 1999-09-13 2000-09-12 Genetic markers of toxicity, preparation and uses thereof
AT00962602T ATE263255T1 (de) 1999-09-13 2000-09-12 Genetische toxizitätsmarker, herstellung und verwendung
EP00962602A EP1220950B9 (fr) 1999-09-13 2000-09-12 Marqueurs genetiques de la toxicite, preparation et utilisation
CA002380383A CA2380383A1 (fr) 1999-09-13 2000-09-12 Marqueurs genetiques de la toxicite, preparation et utilisations
JP2001523800A JP2003509066A (ja) 1999-09-13 2000-09-12 遺伝学的毒性マーカー、その調製及び使用
DE60009530T DE60009530T2 (de) 1999-09-13 2000-09-12 Genetische toxizitätsmarker, herstellung und verwendung
ES00962602T ES2216958T3 (es) 1999-09-13 2000-09-12 Marcadores geneticos de la toxicidad, preparacion y utilizacion de los mismos.
DK00962602T DK1220950T3 (da) 1999-09-13 2000-09-12 Genetiske toksicitetsmarkörer, deres fremstilling og anvendelse
AU74269/00A AU783310B2 (en) 1999-09-13 2000-09-12 Genetic markers of toxicity, preparation and uses thereof
US10/070,676 US20030059788A1 (en) 1999-09-13 2001-03-22 Genetic markers of toxicity, preparation and uses thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9911405A FR2798392B1 (fr) 1999-09-13 1999-09-13 Marqueurs genetiques de la toxicite, preparation et utilisations

Publications (2)

Publication Number Publication Date
FR2798392A1 FR2798392A1 (fr) 2001-03-16
FR2798392B1 true FR2798392B1 (fr) 2005-07-15

Family

ID=9549766

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9911405A Expired - Fee Related FR2798392B1 (fr) 1999-09-13 1999-09-13 Marqueurs genetiques de la toxicite, preparation et utilisations

Country Status (13)

Country Link
US (2) US6509153B1 (enExample)
EP (1) EP1220950B9 (enExample)
JP (1) JP2003509066A (enExample)
AT (1) ATE263255T1 (enExample)
AU (1) AU783310B2 (enExample)
CA (1) CA2380383A1 (enExample)
DE (1) DE60009530T2 (enExample)
DK (1) DK1220950T3 (enExample)
ES (1) ES2216958T3 (enExample)
FR (1) FR2798392B1 (enExample)
IL (1) IL148615A0 (enExample)
PT (1) PT1220950E (enExample)
WO (1) WO2001020029A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6881571B1 (en) * 1998-03-11 2005-04-19 Exonhit Therapeutics S.A. Qualitative differential screening
FR2798673B1 (fr) * 1999-09-16 2004-05-28 Exonhit Therapeutics Sa Methodes et compositions pour la detection d'evenements pathologiques
US7361488B2 (en) * 2000-02-07 2008-04-22 Illumina, Inc. Nucleic acid detection methods using universal priming
DE60236559D1 (de) * 2001-08-24 2010-07-08 Daikin Ind Ltd Verfahren zum Nachweis toxischer Substanzen
GB0410105D0 (en) * 2004-05-06 2004-06-09 Amersham Biosciences Uk Ltd Method for characterising compounds
US20080194417A1 (en) * 2005-03-09 2008-08-14 Luca Barella Method for Measuring and Comparing the Activity of Biologically Active Compounds
CN101611315A (zh) * 2006-10-23 2009-12-23 Uab研究基金会 用于对抗癌试剂敏感的癌症的生物标记物及其用途
DE102010024898B4 (de) * 2010-06-24 2012-10-25 Merck Patent Gmbh Genexpressionsanalysen zur Charakterisierung und Identifizierung genotoxischer Verbindungen

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965188A (en) * 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US5985549A (en) * 1985-10-22 1999-11-16 University Of Massachusetts Non-isotopic in-situ hybridization method for detection of nucleic acids
US4888278A (en) * 1985-10-22 1989-12-19 University Of Massachusetts Medical Center In-situ hybridization to detect nucleic acid sequences in morphologically intact cells
US5057410A (en) * 1988-08-05 1991-10-15 Cetus Corporation Chimeric messenger RNA detection methods
US5143854A (en) * 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US6309822B1 (en) * 1989-06-07 2001-10-30 Affymetrix, Inc. Method for comparing copy number of nucleic acid sequences
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
US5674682A (en) * 1992-10-29 1997-10-07 Thomas Jefferson University Nucleic acid primers for detecting micrometastasis of prostate cancer
US5521297A (en) * 1993-06-04 1996-05-28 Salk Institute Biotechnology/Industrial Associates Nucleic acids encoding human metabotropic glutamate receptors
US5837832A (en) * 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
US5529925A (en) * 1993-12-03 1996-06-25 St. Jude Children's Research Hospital Nucleic acid sequences and fusion proteins present in human t(2;5) lymphoma
US5484702A (en) * 1994-01-27 1996-01-16 Research Foundation Of The State University Of New York At Buffalo Method for preselecting recombinant clones containing a specific nucleic acid sequence and subsequent transformation with preselected clones
US5679541A (en) * 1994-02-14 1997-10-21 California Institute Of Technology Programmed cell death antagonist protein
PH31414A (en) * 1994-02-24 1998-10-29 Boehringer Ingelheim Int Method of diagnosing cancer precancerous state, orsusceptibility to other forms of diseases by anal ysis of irf-1 specific rna in biopsy samples.
US5767258A (en) * 1995-05-12 1998-06-16 The Johns Hopkins University School Of Medicine Cell cycle regulatory gene
WO1997013877A1 (en) * 1995-10-12 1997-04-17 Lynx Therapeutics, Inc. Measurement of gene expression profiles in toxicity determination
US5922535A (en) * 1995-11-07 1999-07-13 Huo; Li Identifying sequence differences in nucleic acid populations
FR2775984B1 (fr) * 1998-03-11 2006-09-15 Bioscreen Therapeutics Sa Criblage differentiel qualitatif
US6881571B1 (en) * 1998-03-11 2005-04-19 Exonhit Therapeutics S.A. Qualitative differential screening
FR2755984B1 (fr) * 1996-11-15 2002-12-27 Bourachot Philippe Borne escamotable
US6060240A (en) * 1996-12-13 2000-05-09 Arcaris, Inc. Methods for measuring relative amounts of nucleic acids in a complex mixture and retrieval of specific sequences therefrom
CA2225187A1 (en) * 1997-07-14 1999-01-14 Universite D'ottawa/ University Of Ottawa Xaf genes and polypeptides: methods and reagents for modulating apoptosis
US6849400B1 (en) * 1997-07-23 2005-02-01 Gen-Probe Incorporated Methods for detecting and measuring spliced nucleic acids
GB9717766D0 (en) * 1997-08-22 1997-10-29 Zeneca Ltd Methods
US6432640B1 (en) * 1997-09-17 2002-08-13 The Johns Hopkins University P53-induced apoptosis
DE69925362T2 (de) * 1998-02-23 2006-01-19 Phylonix Pharmaceuticals Inc., Cambridge Screeningverfahren für die aktivität von agenzien unter verwendung von teleosten
JPH11262621A (ja) * 1998-03-17 1999-09-28 Ebara Corp 除湿空調装置
US6168920B1 (en) * 1998-08-10 2001-01-02 Incyte Genomics, Inc. Extracellular adhesive proteins
WO2000012760A2 (en) * 1998-08-28 2000-03-09 Incyte Pharmaceuticals, Inc. Toxicological response markers
US6160105A (en) * 1998-10-13 2000-12-12 Incyte Pharmaceuticals, Inc. Monitoring toxicological responses
FR2798673B1 (fr) * 1999-09-16 2004-05-28 Exonhit Therapeutics Sa Methodes et compositions pour la detection d'evenements pathologiques
EP1654371A4 (en) * 2001-06-21 2010-02-10 Verenium Corp METHOD FOR PRODUCING PURE ENANTIOMERIC PURELY COMPOUNDS AND SELECTION OF ENANTIOSELECTIVE ENZYMES

Also Published As

Publication number Publication date
EP1220950B9 (fr) 2004-11-03
ATE263255T1 (de) 2004-04-15
AU783310B2 (en) 2005-10-13
ES2216958T3 (es) 2004-11-01
US20030059788A1 (en) 2003-03-27
US6509153B1 (en) 2003-01-21
EP1220950B1 (fr) 2004-03-31
WO2001020029A3 (fr) 2001-11-29
JP2003509066A (ja) 2003-03-11
IL148615A0 (en) 2002-09-12
AU7426900A (en) 2001-04-17
PT1220950E (pt) 2004-07-30
FR2798392A1 (fr) 2001-03-16
DE60009530T2 (de) 2005-02-03
WO2001020029A2 (fr) 2001-03-22
DE60009530D1 (de) 2004-05-06
CA2380383A1 (fr) 2001-03-22
DK1220950T3 (da) 2004-08-02
EP1220950A2 (fr) 2002-07-10

Similar Documents

Publication Publication Date Title
ATE480643T1 (de) Homogener nachweis von analyten
Tallman et al. Far‐red fluorogenic probes for esterase and lipase detection
DE60235005D1 (de) Nachweis der instabilität von mikrosatelliten und
DK1381697T3 (da) Cirkulær probe-amplifikation (CPA) af ringformede nukleinsyremolekyler
BRPI0407397A (pt) Evento de algodão mon 88913 e composições e métodos para sua detecção
FR2798392B1 (fr) Marqueurs genetiques de la toxicite, preparation et utilisations
GB2430740A (en) System and method for tracking and quatitating chemical entites
Cann et al. Measuring kinase activity—a global challenge
WO2004063334A8 (en) Molecular cardiotoxicology modeling
ATE421595T1 (de) Zusammensetzungen und verfahren zum nachweis und zur quantifizierung von cox-2-aktivität und 2- arachidonylglycerin-metaboliten
Heidary et al. A light‐activated metal complex targets both DNA and RNA in a fluorescent in vitro transcription and translation assay
BRPI0414283A (pt) métodos, composições e kits para a concentração e detecção de microorganismos
DE69941690D1 (de) Methoden, testsätze und kompositionen zur detektion und quantifizierung von zielsequenzen
Huang et al. Kinetic analysis of PI3K reactions with fluorescent PIP2 derivatives
BR0303012A (pt) Avaliação de câncer colorretal
MXPA05002934A (es) Composiciones, metodos y kits para deteccion de un antigeno en una celula y en una mezcla biologica.
BR0303091A (pt) Avaliação de câncer colorretal
Zhang et al. A sensitive assay of telomerase activity based on the controllable aggregation of quantum dots
Chen et al. A label-free fluorescence turn-on sensor for rapid detection of cysteine
Jiang et al. DNA-hosted Hoechst dyes: application for label-free fluorescent monitoring of endonuclease activity and inhibition
Liu et al. Double blocking gap-filling-ligation coupled with cascade isothermal amplification for ultrasensitive quantification of N 6-methyladenosine
Shin et al. A Comparative Analysis of Acyl‐Homoserine Lactone Synthase Assays
BR9708256A (pt) Processo para identificar genes com expresão específica ao síto ou de síto preferido em células de marcacção específicas presentes em um ambiente de células diferente ou não daquele de sua origem e uso do mesmo
EA199800438A1 (ru) Способ и набор для количественного определения и обнаружения микроорганизмов
NO20053177D0 (no) Fremgangsmater og sammensetninger for karakterisering av redoksreagenssytemenzym.

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20070531